TRU · TransUnion
Price & Indicators
Up next
AI Brief
TL;DR.
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Ask ALVIS about this →Equibles Rating
blended score · not investment adviceBlended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders BuyIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Adjusted Diluted Earnings per Share non-GAAP | $2.41 | Six Months Ended June 30, 2026 | — |
|
|
|||
| Adjusted Effective Tax Rate non-GAAP | 25.1% | Six Months Ended June 30, 2026 | — |
|
|
|||
| Adjusted Net Income non-GAAP | $467.8M | Six Months Ended June 30, 2026 | — |
|
|
|||
| Consolidated Adjusted EBITDA non-GAAP | $1.74B | Trailing Twelve Months Ended June 30, 2026 | +5.5% |
|
|
|||
| Consolidated Adjusted EBITDA margin non-GAAP | 35% | Six Months Ended June 30, 2026 | — |
|
|
|||
| International Adjusted EBITDA non-GAAP | $258.5M | Six Months Ended June 30, 2026 | — |
|
|
|||
| Leverage Ratio non-GAAP | 2.6 | Trailing Twelve Months Ended June 30, 2026 | — |
| Leverage Ratio Adjusted EBITDA non-GAAP | $1.79B | Trailing Twelve Months Ended June 30, 2026 | — |
| U.S. Markets Adjusted EBITDA non-GAAP | $717.9M | Six Months Ended June 30, 2026 | — |
|
|
|||
| Adjusted Basic Earnings per Share non-GAAP | $1.19 | Three Months Ended March 31, 2026 | — |
| Adjusted Diluted EPS non-GAAP | $1.18 | Q1 2026 | — |
| Dividends paid | $25M | Q1 2026 | — |
| Net Debt non-GAAP | $4.87B | Trailing Twelve Months Ended March 31, 2026 | — |
| Organic constant currency revenue non-GAAP | 11% | Q1 2026 | — |
| Organic constant currency revenue ex. FICO mortgage royalties non-GAAP | 7% | Q1 2026 | — |
| Share repurchases | $25M | Q1 2026 | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
Financial Data & Stock Exchanges — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
TRU
this stock
TransUnion
|
$16.36B | -1.0% | +9.4% | 23.5 | 4.4% |
|
SPGI
S&P Global Inc.
|
$136.23B | — | +7.1% | 29.1 | 2.8% |
|
CME
Cme Group Inc.
|
$98.88B | +2.2% | +6.4% | 23.3 | 1.7% |
|
ICE
Intercontinental Exchange, Inc.
|
$90.52B | +0.6% | -2.1% | 22.8 | 1.4% |
|
MCO
Moodys Corp /De/
|
$87.73B | +0.1% | +16.6% | 32.1 | 1.8% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| TRU | +7.8% | +10.9% | +8.4% | +8.0% | -1.0% |
| SPY | -1.2% | +3.3% | +12.2% | +2.2% | +12.0% |
| vs SPY | +9.0% | +7.6% | -3.8% | +5.8% | -13.0% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.